TP53 and cancer: These individuals are first diagnosed with early-onset cancers and a family history of selected cancers; germ line Tp53 mutations are subsequently detected with 70–90 percent penetrance for the development of a cancer, depending upon the Tp53 allele and the sex of the patient (Malkin et al, 1990; Guha & Malkin, 2017).